Back
Phathom Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
PHAT
Phathom Pharmaceuticals
Last Price:
$7.96
Seasonality Move:
2.88%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.
Phathom Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.81 | Sell |
| 20-day SMA: | 9.15 | Sell |
| 50-day SMA: | 7.06 | Buy |
| 200-day SMA: | 8.3 | Sell |
| 8-day EMA: | 7.64 | Buy |
| 20-day EMA: | 5.17 | Buy |
| 50-day EMA: | 2.65 | Buy |
| 200-day EMA: | 0.76 | Buy |
Phathom Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.34 | Buy |
| Relative Strength Index (14 RSI): | 43.36 | Sell |
| Chaikin Money Flow: | -880617 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.64 - 10.2) | Sell |
| Bollinger Bands (100): | (3.64 - 8.36) | Buy |
Phathom Pharmaceuticals Technical Analysis
| Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Phathom Pharmaceuticals Stock
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 7.95 while PHAT 8-day simple moving average is 8.81, which is a Sell signal.
-
The stock price of PHAT is 7.95 while Phathom Pharmaceuticals 20-day SMA is 9.15, which makes it a Sell.
-
Phathom Pharmaceuticals 50-day simple moving average is 7.06 while PHAT share price is 7.95, making it a Buy technically.
-
PHAT stock price is 7.95 and Phathom Pharmaceuticals 200-day simple moving average is 8.30, creating a Sell signal.
PHAT Technical Analysis vs Fundamental Analysis
Sell
23
Phathom Pharmaceuticals (PHAT)
is a Sell
Is Phathom Pharmaceuticals a Buy or a Sell?
-
Phathom Pharmaceuticals stock is rated a SellThe current Phathom Pharmaceuticals [PHAT] share price is $7.95. The Score for PHAT is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Phathom Pharmaceuticals Stock Info
Market Cap:
555M
Price in USD:
7.95
Share Volume:
1M
Phathom Pharmaceuticals 52-Week Range
52-Week High:
19.71
52-Week Low:
2.21
Sell
23
Phathom Pharmaceuticals (PHAT)
is a Sell
Phathom Pharmaceuticals Share Price Forecast
-
What is the Phathom Pharmaceuticals stock price today?The Phathom Pharmaceuticals stock price is 7.95 USD today.
-
Will PHAT stock go up or go down?Phathom Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Phathom Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Phathom Pharmaceuticals is overvalued.
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 7.95 while PHAT 8-day exponential moving average is 7.64, which is a Buy signal.
-
The stock price of PHAT is 7.95 while Phathom Pharmaceuticals 20-day EMA is 5.17, which makes it a Buy.
-
Phathom Pharmaceuticals 50-day exponential moving average is 2.65 while PHAT share price is 7.95, making it a Buy technically.
-
PHAT stock price is 7.95 and Phathom Pharmaceuticals 200-day simple moving average is 0.76, creating a Buy signal.
Fundamental Analysis of Phathom Pharmaceuticals
Is Phathom Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.29 per share, an increase this year of $1.78 per share, and an increase next year of $2.34 per share.
Technical Analysis of Phathom Pharmaceuticals
Should I short Phathom Pharmaceuticals stock?
-
PHAT Moving Average Covergence Divergence (MACD) indicator is 2.34, suggesting Phathom Pharmaceuticals is a Buy
-
Phathom Pharmaceuticals Relative Strength Index (RSI) is 43.36, which suggest Phathom Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Phathom Pharmaceuticals is (8.64 - 10.2), which suggest Phathom Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Phathom Pharmaceuticals is (3.64 - 8.36), which suggest Phathom Pharmaceuticals is a Buy
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.